Clinical Trials Browser

OTHER × Osteosarcoma × Sorafenib × Clear all

NCT01518413 2015-02-27

Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors

Phase 1 Completed

Brain Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma